Neurological Surgery

Publications

Found 13 results

Filters: Author is Parashar, Bhupesh [Clear All Filters]

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

S

Hirschfeld CB, Schwartz TH, Parashar B, A Wernicke G. 2016. Seed migration to the spinal canal after postresection brachytherapy to treat a large brain metastasis.. Brachytherapy. 15(5):637-41.

R

A Wernicke G, Yondorf M, Parashar B, Trichter S, Schwartz TH. 2015. Response.. J Neurosurg. 123(4):1111-2.

Yondorf MZ, Schwartz TH, Boockvar JA, Pannullo S, Stieg P, Sabbas A, Pavese A, Trichter S, Nedialkova L, Parashar B et al.. 2017. Radiation Exposure and Safety Precautions Following 131Cs Brachytherapy in Patients with Brain Tumors.. Health Phys. 112(4):403-408.

P

Shafiq ARaza, A Wernicke G, Riley CAlex, Morgenstern PF, Nedialkova L, Pannullo SC, Parashar B, Magge R, Schwartz TH. 2019. Placement of cesium-131 permanent brachytherapy seeds using the endoscopic endonasal approach for recurrent anaplastic skull base meningioma: case report and technical note.. J Neurosurg. 132(3):921-926.

O

Julie DAR, Ahmed Z, Karceski SC, Pannullo SC, Schwartz TH, Parashar B, A Wernicke G. 2019. An overview of anti-epileptic therapy management of patients with malignant tumors of the brain undergoing radiation therapy.. Seizure. 70:30-37.

Eljalby M, Pannullo SC, Schwartz TH, Parashar B, A Wernicke G. 2019. Optimal Timing and Sequence of Immunotherapy When Combined with Stereotactic Radiosurgery in the Treatment of Brain Metastases.. World Neurosurg. 127:397-404.

N

Pham A, Yondorf MZ, Parashar B, Scheff RJ, Pannullo SC, Ramakrishna R, Stieg PE, Schwartz TH, A Wernicke G. 2016. Neurocognitive function and quality of life in patients with newly diagnosed brain metastasis after treatment with intra-operative cesium-131 brachytherapy: a prospective trial.. J Neurooncol. 127(1):63-71.

I

Mahase SS, Navrazhina K, Schwartz TH, Parashar B, A Wernicke G. 2019. Intraoperative brachytherapy for resected brain metastases.. Brachytherapy. 18(3):258-270.

D

Yondorf MZ, Faraz S, Smith AW, Sabbas A, Parashar B, Schwartz TH, A Wernicke G. 2020. Dosimetric differences between cesium-131 and iodine-125 brachytherapy for the treatment of resected brain metastases.. J Contemp Brachytherapy. 12(4):311-316.

C

A Wernicke G, Taube S, Smith AW, Herskovic A, Parashar B, Schwartz TH. 2020. Cs-131 brachytherapy for patients with recurrent glioblastoma combined with bevacizumab avoids radiation necrosis while maintaining local control.. Brachytherapy. 19(5):705-712.

A Wernicke G, Yondorf MZ, Parashar B, Nori D, Chao KSClifford, Boockvar JA, Pannullo S, Stieg P, Schwartz TH. 2016. The cost-effectiveness of surgical resection and cesium-131 intraoperative brachytherapy versus surgical resection and stereotactic radiosurgery in the treatment of metastatic brain tumors.. J Neurooncol. 127(1):145-53.

A Wernicke G, Hirschfeld CB, Smith AW, Taube S, Yondorf MZ, Parashar B, Nedialkova L, Kulidzhanov F, Trichter S, Sabbas A et al.. 2017. Clinical Outcomes of Large Brain Metastases Treated With Neurosurgical Resection and Intraoperative Cesium-131 Brachytherapy: Results of a Prospective Trial.. Int J Radiat Oncol Biol Phys. 98(5):1059-1068.

A Wernicke G, Smith AW, Taube S, Yondorf MZ, Parashar B, Trichter S, Nedialkova L, Sabbas A, Christos P, Ramakrishna R et al.. 2017. Cesium-131 brachytherapy for recurrent brain metastases: durable salvage treatment for previously irradiated metastatic disease.. J Neurosurg. 126(4):1212-1219.